237 related articles for article (PubMed ID: 9184127)
1. Blood-brain barrier permeability during the development of experimental bacterial meningitis in the rat.
Kim KS; Wass CA; Cross AS
Exp Neurol; 1997 May; 145(1):253-7. PubMed ID: 9184127
[TBL] [Abstract][Full Text] [Related]
2. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat.
Kim KS; Wass CA; Cross AS; Opal SM
Lymphokine Cytokine Res; 1992 Dec; 11(6):293-8. PubMed ID: 1477182
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis.
Boje KM
Brain Res; 1996 May; 720(1-2):75-83. PubMed ID: 8782899
[TBL] [Abstract][Full Text] [Related]
4. A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis.
Barichello T; Pereira JS; Savi GD; Generoso JS; Cipriano AL; Silvestre C; Petronilho F; Dal-Pizzol F; Vilela MC; Teixeira AL
J Neuroimmunol; 2011 Apr; 233(1-2):12-7. PubMed ID: 21109308
[TBL] [Abstract][Full Text] [Related]
5. Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation.
Quagliarello VJ; Long WJ; Scheld WM
J Clin Invest; 1986 Apr; 77(4):1084-95. PubMed ID: 3514671
[TBL] [Abstract][Full Text] [Related]
6. Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat.
Lesse AJ; Moxon ER; Zwahlen A; Scheld WM
J Clin Invest; 1988 Jul; 82(1):102-9. PubMed ID: 3260602
[TBL] [Abstract][Full Text] [Related]
7. Strategy of Escherichia coli for crossing the blood-brain barrier.
Kim KS
J Infect Dis; 2002 Dec; 186 Suppl 2():S220-4. PubMed ID: 12424701
[TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular permeability changes during experimental meningitis in the rat.
Boje KM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1199-203. PubMed ID: 7562488
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria.
Spector R; Lorenzo AV
J Clin Invest; 1974 Aug; 54(2):316-25. PubMed ID: 4546548
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis.
Mustafa MM; Ramilo O; Olsen KD; Franklin PS; Hansen EJ; Beutler B; McCracken GH
J Clin Invest; 1989 Oct; 84(4):1253-9. PubMed ID: 2794062
[TBL] [Abstract][Full Text] [Related]
11. Role of S fimbriae in Escherichia coli K1 binding to brain microvascular endothelial cells in vitro and penetration into the central nervous system in vivo.
Wang Y; Wen ZG; Kim KS
Microb Pathog; 2004 Dec; 37(6):287-93. PubMed ID: 15619424
[TBL] [Abstract][Full Text] [Related]
12. Current concepts on Escherichia coli K1 translocation of the blood-brain barrier.
Xie Y; Kim KJ; Kim KS
FEMS Immunol Med Microbiol; 2004 Nov; 42(3):271-9. PubMed ID: 15477040
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of tyrosine phosphatase SHP2 in experimental pneumococcal meningitis: correlation with tumor necrosis factor-alpha and cerebrospinal fluid pleocytosis.
Feng M; Sun R; Zhang C; Sun E; Wei S; Wan J; Sun R
J Child Neurol; 2008 Mar; 23(3):287-92. PubMed ID: 18305318
[TBL] [Abstract][Full Text] [Related]
14. A new method for measuring blood-brain barrier permeability demonstrated with Europium-bound albumin during experimental lipopolysaccharide (LPS) induced meningitis in the rat.
Ivey NS; Martin EN; Scheld WM; Nathan BR
J Neurosci Methods; 2005 Mar; 142(1):91-5. PubMed ID: 15652621
[TBL] [Abstract][Full Text] [Related]
15. Haemophilus influenzae b bacteremia and meningitis in infant rabbits after intranasal inoculation.
San Joaquin VH; Altshuler GP; Robinson W; Marks MI; Weber A
J Lab Clin Med; 1983 Dec; 102(6):939-46. PubMed ID: 6606008
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-LPS inner core antibodies protect against experimental hematogenous Haemophilus influenzae type b meningitis.
Borrelli S; Diab A; Lindberg A; Svanborg C
Microb Pathog; 2000 Jan; 28(1):1-8. PubMed ID: 10623558
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of meningeal invasion by a bacterial extracellular pathogen, the example of Neisseria meningitidis.
Join-Lambert O; Morand PC; Carbonnelle E; Coureuil M; Bille E; Bourdoulous S; Nassif X
Prog Neurobiol; 2010 Jun; 91(2):130-9. PubMed ID: 20026234
[TBL] [Abstract][Full Text] [Related]
19. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammatory role of prostaglandins during experimental meningitis: evidence suggestive of an in vivo relationship between nitric oxide and prostaglandins.
Boje KM; Jaworowicz D; Raybon JJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):319-25. PubMed ID: 12490607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
